Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Bausch Health Companies Inc    BHC   CA0717341071

BAUSCH HEALTH COMPANIES INC

(BHC)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Bausch Health : To Reduce Debt By Additional $100 Million Using Cash Generated From Operations

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/25/2019 | 08:01am EDT

LAVAL, Quebec, June 25, 2019 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it put in notice to pay down an additional $100 million of its senior secured term loans this week, using cash generated from operations. After this payment, the Company will have eliminated all mandatory amortization for the first quarter of 2020.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Caution Regarding Forward-Looking Information and "Safe Harbor" Statement
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to risks and uncertainties discussed in the Company's most recent annual and quarterly reports and detailed from time to time in the Company's other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor and Media Contact:  
Arthur Shannon   
arthur.shannon@bauschhealth.com   
(514) 856-3855       
(877) 281-6642 (toll free)   

Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-to-reduce-debt-by-additional-100-million-using-cash-generated-from-operations-300874078.html

SOURCE Bausch Health Companies Inc.

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAUSCH HEALTH COMPANIES IN
08/07BAUSCH HEALTH : FDA Accepts NDA For IDP-123 Lotion for Acne
DJ
08/07BAUSCH HEALTH : Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP..
AQ
08/06BAUSCH HEALTH : Management's Discussion and Analysis of Financial Condition and ..
AQ
08/06BAUSCH HEALTH : reports better Q2 results, raises 2019 estimated revenue, earnin..
AQ
08/06BAUSCH : 2Q Earnings Snapshot
AQ
08/06BAUSCH HEALTH : Increases Revenue, Adjusted Ebitda Guidance
DJ
08/06BAUSCH HEALTH : Loss Lessens As Expenses Fall
DJ
08/06BAUSCH HEALTH COMPANIES INC. : Results of Operations and Financial Condition (fo..
AQ
08/06BAUSCH HEALTH COMPANIES INC. : Announces Second-Quarter 2019 Results And Raises ..
PR
08/01BAUSCH HEALTH : + Lomb Initiates First Clinical For Technolas Teneo Excimer Lase..
AQ
More news
Financials (USD)
Sales 2019 8 512 M
EBIT 2019 3 236 M
Net income 2019 -426 M
Debt 2019 22 721 M
Yield 2019 -
P/E ratio 2019 -19,0x
P/E ratio 2020 32,7x
EV / Sales2019 3,36x
EV / Sales2020 3,09x
Capitalization 5 851 M
Chart BAUSCH HEALTH COMPANIES INC
Duration : Period :
Bausch Health Companies Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAUSCH HEALTH COMPANIES IN
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price
Last Close Price 22,10  $
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Joseph C. Papa Chairman & Chief Executive Officer
Paul S. Herendeen Chief Financial Officer & Executive Vice President
Jerzy Janeczko Head-Information Technology
Calvin W. Roberts Chief Medical Officer & Senior Vice President
Robert N. Power Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BAUSCH HEALTH COMPANIES INC16.44%7 785
JOHNSON & JOHNSON1.72%346 443
ROCHE HOLDING LTD.11.71%236 383
MERCK AND COMPANY13.49%222 036
NOVARTIS18.13%204 408
PFIZER-20.11%194 029